Phio Pharmaceuticals Corp. (PHIO)
NASDAQ: PHIO · Real-Time Price · USD
1.165
-0.005 (-0.43%)
Mar 6, 2026, 1:30 PM EST - Market open
Phio Pharmaceuticals Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Cost of Revenue | - | 3.64 | 6.33 | 7.01 | 8.89 | |
| Gross Profit | - | -3.64 | -6.33 | -7.01 | -8.89 | |
| Selling, General & Admin | 4.6 | 3.74 | 4.37 | 4.45 | 4.63 | |
| Research & Development | 4.62 | - | - | - | - | |
| Operating Expenses | 9.22 | 3.74 | 4.37 | 4.45 | 4.63 | |
| Operating Income | -9.22 | -7.39 | -10.7 | -11.46 | -13.51 | |
| Interest Expense | - | - | -0.01 | - | - | |
| Interest & Investment Income | 0.52 | 0.23 | - | - | - | |
| Other Non Operating Income (Expenses) | 0 | 0.01 | 0.01 | -0.02 | -0.01 | |
| EBT Excluding Unusual Items | -8.7 | -7.15 | -10.7 | -11.48 | -13.52 | |
| Asset Writedown | - | - | -0.13 | - | - | |
| Other Unusual Items | - | - | - | - | 0.23 | |
| Pretax Income | -8.7 | -7.15 | -10.83 | -11.48 | -13.29 | |
| Net Income | -8.7 | -7.15 | -10.83 | -11.48 | -13.29 | |
| Net Income to Common | -8.7 | -7.15 | -10.83 | -11.48 | -13.29 | |
| Shares Outstanding (Basic) | 6 | 1 | 0 | 0 | 0 | |
| Shares Outstanding (Diluted) | 6 | 1 | 0 | 0 | 0 | |
| Shares Change (YoY) | 659.91% | 240.15% | 83.32% | 6.30% | 179.70% | |
| EPS (Basic) | -1.45 | -9.08 | -46.76 | -90.91 | -111.84 | |
| EPS (Diluted) | -1.45 | -9.08 | -46.76 | -90.91 | -111.87 | |
| Free Cash Flow | -7.99 | -7.11 | -10.75 | -12.25 | -11.91 | |
| Free Cash Flow Per Share | -1.33 | -9.03 | -46.45 | -97.00 | -100.24 | |
| EBITDA | -9.22 | -7.39 | -10.64 | -11.39 | -13.44 | |
| D&A For EBITDA | 0 | 0 | 0.06 | 0.07 | 0.08 | |
| EBIT | -9.22 | -7.39 | -10.7 | -11.46 | -13.51 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.